AstraZeneca ZENITH-CKD
Efficacy, safety and tolerability of treatment with zibotentan and dapagliflozin in combination and dapagliflozin 10 mg as monotherapy in participants with chronic kidney disease (CKD)
Bayer: FIND-CKD 21177
Learn if finerenone helps to slow down the worsening of the participants’ non-diabetic CKD compared to a placebo.
Novo Nordisk Zeus: EX6018-4758
Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation.